G Klamer

Summary

Affiliation: University of New South Wales
Country: Australia

Publications

  1. ncbi Using small molecule GSK3β inhibitors to treat inflammation
    G Klamer
    Children s Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Randwick, NSW, Australia
    Curr Med Chem 17:2873-81. 2010
  2. ncbi GSK-3β inhibition promotes early engraftment of ex vivo-expanded haematopoietic stem cells
    A Dolnikov
    Sydney Cord and Marrow Transplant Laboratory, Sydney Children s Hospital, Randwick, NSW, Australia School of Women s and Children s Health, University of New South Wales, Sydney, NSW, Australia
    Cell Prolif 47:113-23. 2014

Collaborators

Detail Information

Publications2

  1. ncbi Using small molecule GSK3β inhibitors to treat inflammation
    G Klamer
    Children s Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Randwick, NSW, Australia
    Curr Med Chem 17:2873-81. 2010
    ..The combined anti-proliferative and anti-inflammatory properties of small molecule inhibitors of GSK3β make them an attractive treatment modality towards the control of inflammation...
  2. ncbi GSK-3β inhibition promotes early engraftment of ex vivo-expanded haematopoietic stem cells
    A Dolnikov
    Sydney Cord and Marrow Transplant Laboratory, Sydney Children s Hospital, Randwick, NSW, Australia School of Women s and Children s Health, University of New South Wales, Sydney, NSW, Australia
    Cell Prolif 47:113-23. 2014
    ....